| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/06/2007 | EP1792910A2 Effectors of dipeptidyl peptidase IV for topical use |
| 06/06/2007 | EP1792626A1 Treatment of obesity by brain delivery of alpha-MSH and analogs thereof |
| 06/06/2007 | EP1792625A1 Use of a phosphatidylserine/polypeptide conjugate for inducing autoimmunity in the treatment of cancers |
| 06/06/2007 | EP1792624A1 Modified amino acids and compositions comprising them for delivering active agents |
| 06/06/2007 | EP1792620A1 Medicinal composition containing diabetes remedy |
| 06/06/2007 | EP1792611A1 Matrix controlled transdermal system for stable derivatives of ACE inhibitors |
| 06/06/2007 | EP1791969A2 A method of treating cancer |
| 06/06/2007 | EP1791863A1 Truncated lhrh formulations |
| 06/06/2007 | EP1791859A1 Chemokine binding activity of viral tnf receptors and related proteins |
| 06/06/2007 | EP1791858A2 Modified vp1-capsid protein of parvovirus b19 |
| 06/06/2007 | EP1791854A2 Methods of treating disorders having a component of mercury toxicity |
| 06/06/2007 | EP1791560A2 Polypeptides for inducing a protective immune response against staphylococcus aureus |
| 06/06/2007 | EP1791555A1 Methods for treating local tracheal, bronchial or alveolar bleeding or hemoptysis |
| 06/06/2007 | EP1791554A2 Pharmaceutical compositions containing insulin and insulinotropic peptide |
| 06/06/2007 | EP1791553A2 Compositions for delivering peptide yy and pyy agonists |
| 06/06/2007 | EP1791552A2 Protein a compositions and methods of use |
| 06/06/2007 | EP1791551A2 Method and device for diagnosing and treating insulin-like growth factor deficiency disorders |
| 06/06/2007 | EP1791529A2 P277 peptide formulations or variants thereof having optimised stability |
| 06/06/2007 | EP1791423A1 Compositions and methods for the management of hyperproliferative dermatological conditions |
| 06/06/2007 | EP1620459A4 An intracellular estradiol binding protein, a polynucleotide encoding the same and cell lines overexpressing the same |
| 06/06/2007 | EP1578438B1 Synthetic peptide analogs for the treatment of cancer |
| 06/06/2007 | EP1381431B1 Aromatase inhibition to enhance implantation rate |
| 06/06/2007 | EP1363601B1 Amphoteric liposomes and the use thereof |
| 06/06/2007 | EP1272211B1 Methods and compositions for treating neoplasms |
| 06/06/2007 | EP1229922B1 Aplidine treatment of cancers |
| 06/06/2007 | EP1181056B1 Lim mineralization protein splice variants |
| 06/06/2007 | EP1011711B1 Synergistic effects of op/bmp morphogens and gdnf/ngf neurotrophic factors |
| 06/06/2007 | EP1010430B1 Preventives and ameliorating agents for periodontosis |
| 06/06/2007 | EP1009826B1 Erbb4 receptor-specific neuregulin, related ligands and uses thereof |
| 06/06/2007 | EP0982037B1 Use of tcf-ii for preventing or treating sepsis |
| 06/06/2007 | EP0954317B1 Use of 7 apha-substituted steroids to treat neuropsychiatric disorders |
| 06/06/2007 | EP0939824B1 Reagents and methods useful for detecting diseases of the breast |
| 06/06/2007 | EP0920446B1 Conformationally constrained backbone cyclized somatostatin analogs |
| 06/06/2007 | EP0886679B1 Parapoxviruses containing foreign dna, their production and their use in vaccines |
| 06/06/2007 | EP0862625B1 Methods for modulation of cholesterol transport |
| 06/06/2007 | EP0742723B1 Homologous recombination for universal donor cells and chimeric mammalian hosts |
| 06/06/2007 | EP0683234B2 Antibody against beta-amyloid or their derivative and use thereof |
| 06/06/2007 | CN1976948A 修饰的Exendins及其应用 Modified Exendins Its Applications |
| 06/06/2007 | CN1976947A Biologically active peptide VAPEEHPTLLTEAPLNPK derivatives |
| 06/06/2007 | CN1976945A Isopeptide gap junction modulators |
| 06/06/2007 | CN1976942A Nucleic acid analysis method for identification of FC receptor polymorphisms |
| 06/06/2007 | CN1976720A Compositions and methods for treatment of severe acute respiratory syndrome (SARS) |
| 06/06/2007 | CN1976715A Epitopes related to coeliac disease |
| 06/06/2007 | CN1976691A Cysteamines for treating complications of hypercholesterolemia and diabetes |
| 06/06/2007 | CN1974598A Isolated proteins from a traditional Chinese medicine yuzhu and use thereof |
| 06/06/2007 | CN1974596A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 06/06/2007 | CN1973899A Immunomodulator for treating malignant tumor |
| 06/06/2007 | CN1973898A P28 molecule or medicinal preparation containing gene thereof |
| 06/06/2007 | CN1973829A Process of preparing calcitonin microsphere |
| 06/06/2007 | CN1973828A VEGF slowly releasing injection microsphere support and its prepn and use |
| 06/06/2007 | CN1973822A Anticancer composition containing Sirolimus |
| 06/06/2007 | CN1320112C Phytase formulation |
| 06/06/2007 | CN1320104C Bacterial strain for preparing high efficiency capsule glycoprotein immunomodulator, screening and application thereof |
| 06/06/2007 | CN1319987C Gamma-secretase inhibitors |
| 06/06/2007 | CN1319982C Sheep growth hormone releasing hormone gene and its expression product and application |
| 06/06/2007 | CN1319596C Preparation process of S190 polypeptide vaccine and its application in resisting SARS virus |
| 06/06/2007 | CN1319594C Oxynthomodulin for preventing or treating excess weight |
| 06/06/2007 | CN1319593C Oral enteric-coated microsphere of Thymosin and preparation thereof |
| 06/06/2007 | CN1319592C Pharmaceutical formulations |
| 06/05/2007 | US7227033 Crystalline polymorph of the anhydrous form in synergistic combination with another active ingredient to enhance drug delivery; antidiabetic agents |
| 06/05/2007 | US7227014 Oligonucleotide with 8-50 bases specifically hybridizes with a nucleic acid molecule encoding human apolipoprotein(a) and inhibits its expression |
| 06/05/2007 | US7227008 13-transmembrane protein expressed in prostate cancer |
| 06/05/2007 | US7227005 Vascular endothelial growth factor 2 |
| 06/05/2007 | US7227004 Comprises monoclonal antibody for detection, diagnosis and treatment of cell proliferation disorders |
| 06/05/2007 | US7227003 Anti-TNF antibody fragments |
| 06/05/2007 | US7227002 Human antibodies that bind human 17-A1/EpCAM tumor antigen |
| 06/05/2007 | US7227001 Manganese superoxide dimutase exon 3-deleted isoforms and nucleic acid molecules encoding the isoforms |
| 06/05/2007 | US7227000 PRO polypeptides; monoclonal/humanized antibodies; fusion proteins |
| 06/05/2007 | US7226999 Sepsis shock therapy; anticoagulants; antiinflammatory agents; exhibits an increased resistance towards inactivation by alpha-1-antitrypsin |
| 06/05/2007 | US7226998 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |
| 06/05/2007 | US7226996 Equine Fc epsilon receptor alpha protein |
| 06/05/2007 | US7226995 Use of C-reactive protein to treat immune complex-mediated renal disease |
| 06/05/2007 | US7226990 Extendin derivatives |
| 06/05/2007 | US7226935 Hypoglycemic agent |
| 06/05/2007 | US7226929 drugs such as 6 -Chloro-N-{(3S)-1-[(1S)-1-methyl-2-oxo-2-piperidin-1-ylethyl]-2-oxopyrrolidin-3-yl}naphthalene-2-sulfonamide, used as antithrombotic agents |
| 06/05/2007 | US7226921 An enzyme inhibitor of cysteine proteases, a morpholine-4-carboxyamide 1,3,4-oxadiazole derivatives; for treating arthritis, muscular dystrophy, inflammation, tumor, glomerulonephritis, malaria, periodontal disease |
| 06/05/2007 | US7226916 For oral administration of a preparation having a) long chain polyunsaturated fatty acids, and b) specified phospholipids, and c) compounds that factor in methionine metabolism, such as folate, B vitamins, magnesium and zinc |
| 06/05/2007 | US7226912 Hepatitis C virus non-structural NS3/4A fusion gene |
| 06/05/2007 | US7226911 Hair keratin-associated proteins |
| 06/05/2007 | US7226910 Treatment of female sexual dysfunction with vasoactive intestinal polypeptide agonists |
| 06/05/2007 | US7226909 Methods of inhibiting transmission of a costimulatory signal of lymphocytes |
| 06/05/2007 | US7226908 Use of VEGF and homologues to treat neuron disorders |
| 06/05/2007 | US7226907 Contacting cardiac muscle cells with a neuregulin protein to activate the MAP kinase pathway in cardiac muscle cells and induce remodeling of cardiac muscle cell sarcomeric and cytoskeleton structures or cell-cell adhesions |
| 06/05/2007 | US7226906 Analogs which are topically active but systemically less active, providing therapy to subjects without the risk of systemic side effects |
| 06/05/2007 | US7226905 Process for the preparation of cyclosporin derivatives |
| 06/05/2007 | US7226904 Agents and methods for promoting bone growth |
| 06/05/2007 | US7226903 Interferon beta: remodeling and glycoconjugation of interferon beta |
| 06/05/2007 | US7226902 Complex of a TGF-beta binding protein and a BMP antagonist where the TGF-beta binding protein comprises a sclerostin polypeptide capable of specifically binding a first TGF-beta superfamily member polypeptide from a BMP-5 polypeptide and a BMP-6 polypeptide |
| 06/05/2007 | US7226785 A single-stranded oligonucleotide with a DNA domain having at least one mismatch with respect to genetic sequence to be altered |
| 06/05/2007 | US7226775 Treating the solution with an ionic surfactant to dissociate the endotoxin from the amphiphilic solution; filtering the solution through a molecular weight cut-off filter to retain the amphiphilic drug or vaccine |
| 06/05/2007 | US7226769 nucleotide sequences encoding for the production of enzymes that are mitogenic regulators, that catalyze thyroid hormone biosynthesis and in nematodes catalyze the biogenesis of cuticle; duox proteins |
| 06/05/2007 | US7226758 glial derived neurotrophic factor (GDNF) isolated from serum-free growth conditioned medium of glioblastoma cells; for preventing and treating nerve damage and nerve related diseases such as Parkinson's disease; genetic engineering |
| 06/05/2007 | US7226757 Adding to the protein an aqueous solution of a charged polymer to reduce intermolecular or intramolecular interactions between positively and negatively charged domains; refolding |
| 06/05/2007 | US7226741 Multimerization of HIV-1 Vif protein as a therapeutic target |
| 06/05/2007 | US7226626 Food products and dietary supplements containing phenolated proteins and process for preparing the same |
| 06/05/2007 | US7226618 Colloidal suspension of submicronic particles as vectors for active principles and method for preparing same |
| 06/05/2007 | US7226611 Glycosaminoglycan/collagen complexes and use thereof |
| 06/05/2007 | US7226605 Botulinum toxin in the treatment or prevention of acne |
| 06/05/2007 | US7226601 binds to both the T cell receptor and an MHC class II antigen; superantigen peptide and affinity counterpart are covalently linked; conjugates have the ability to activate and direct T-lymphocytes |
| 06/05/2007 | US7226598 Soluble trimeric coiled-coil peptide for preventing infection and replication of lymphadenopathy associated virus |